ZA9711565B - Vaccine - Google Patents

Vaccine

Info

Publication number
ZA9711565B
ZA9711565B ZA9711565A ZA9711565A ZA9711565B ZA 9711565 B ZA9711565 B ZA 9711565B ZA 9711565 A ZA9711565 A ZA 9711565A ZA 9711565 A ZA9711565 A ZA 9711565A ZA 9711565 B ZA9711565 B ZA 9711565B
Authority
ZA
South Africa
Prior art keywords
vaccine
Prior art date
Application number
ZA9711565A
Other languages
English (en)
Inventor
Jean-Francois Luci Maisonneuve
Vincent Georges Christ Verlant
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of ZA9711565B publication Critical patent/ZA9711565B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
ZA9711565A 1996-12-24 1997-12-23 Vaccine ZA9711565B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9626864.4A GB9626864D0 (en) 1996-12-24 1996-12-24 Vaccine

Publications (1)

Publication Number Publication Date
ZA9711565B true ZA9711565B (en) 1998-08-27

Family

ID=10805014

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9711565A ZA9711565B (en) 1996-12-24 1997-12-23 Vaccine

Country Status (9)

Country Link
EP (1) EP0948352A1 (xx)
JP (1) JP2001507004A (xx)
AR (1) AR011047A1 (xx)
AU (1) AU5763998A (xx)
CA (1) CA2275896A1 (xx)
CO (1) CO4650187A1 (xx)
GB (1) GB9626864D0 (xx)
WO (1) WO1998028005A1 (xx)
ZA (1) ZA9711565B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1486215A3 (en) * 1997-03-21 2006-04-12 Chiron Corporation Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
US5962636A (en) * 1998-08-12 1999-10-05 Amgen Canada Inc. Peptides capable of modulating inflammatory heart disease
US20020061848A1 (en) 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
US7722887B1 (en) * 1999-09-15 2010-05-25 Mogam Biotechnology Research Institute Detoxified mutants of escherichia coli heat-labile enterotoxin
CA2585011C (en) * 2004-10-25 2014-02-18 Statens Serum Institut Chlamydia trachomatis antigens for vaccine and diagnostic use
US8541007B2 (en) 2005-03-31 2013-09-24 Glaxosmithkline Biologicals S.A. Vaccines against chlamydial infection
EA201001322A1 (ru) * 2005-03-31 2011-02-28 Глаксосмитклайн Байолоджикалс С.А. Вакцины против хламидиоза
ES2788728T3 (es) 2010-05-28 2020-10-22 Spixia Biotechnology Ab Antígeno de la MOMP quimérica, método y uso
ES2900757T3 (es) 2015-02-10 2022-03-18 Ohio State Innovation Foundation Plataformas de células B activadas por clamidia y procedimientos de las mismas
CA3004924A1 (en) * 2015-11-10 2017-05-18 Ohio State Innovation Foundation Methods and compositions related to accelerated humoral affinity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6019982A (en) * 1994-08-26 2000-02-01 The Administrators Of The Tulane Educational Fund Mutant enterotoxin effective as a non-toxic oral adjuvant
MX9703676A (es) * 1994-11-17 1998-03-31 Maxim Pharm Inc Inmunogenos para estimular la inmunidad de las mucosas.
GB9506863D0 (en) * 1995-04-03 1995-05-24 Smithkline Beecham Biolog Vaccines
FR2732605B1 (fr) * 1995-04-07 1997-05-16 Pasteur Merieux Serums Vacc Composition destinee a l'induction d'une reponse immunitaire mucosale
NZ312502A (en) * 1995-07-07 1999-03-29 Oravax Inc Clostridium difficile toxins as mucosal adjuvants

Also Published As

Publication number Publication date
CA2275896A1 (en) 1998-07-02
AR011047A1 (es) 2000-08-02
AU5763998A (en) 1998-07-17
JP2001507004A (ja) 2001-05-29
WO1998028005A1 (en) 1998-07-02
EP0948352A1 (en) 1999-10-13
CO4650187A1 (es) 1998-09-03
GB9626864D0 (en) 1997-02-12

Similar Documents

Publication Publication Date Title
HUP9904549A3 (en) Vaccines
GB9712347D0 (en) Vaccine
GB9718901D0 (en) Vaccine
IL136446A0 (en) Vaccine
GB9711990D0 (en) Vaccine
GB9726555D0 (en) Vaccine
GB9720585D0 (en) Vaccine
EP0958373A4 (en) Vaccines.
GB9616351D0 (en) Vaccine composition
ZA979984B (en) Vaccine composition
GB9626864D0 (en) Vaccine
GB9625968D0 (en) Vaccine
ZA982763B (en) Vaccines
GB9417880D0 (en) Vaccine
ZA973824B (en) Vaccines
GB9419969D0 (en) Vaccine
GB9625967D0 (en) Vaccine
GB9625966D0 (en) Vaccine
GB9602617D0 (en) Vaccines
GB9605229D0 (en) Vaccines
GB9604595D0 (en) Vaccines
GB9604596D0 (en) Vaccines
GB9606032D0 (en) Vaccines
GB9614182D0 (en) Vaccines
GB9626882D0 (en) Vaccines